Local News: Farmington, NH 

 | 

Sign Up

 | 

Sign In

Advertisment

Cephalon News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Cephalon News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Cephalon News

News on Cephalon continually updated from thousands of sources around the net.

20 hrs ago | TheStreet.com

Bulls Buy Cephalon, WebMD:Options Recap

Utility AES sees spate of call selling : The electric utility has been dead money for the last three months, and now one investor may be throwing in the towel.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food, Smithfield Foods

Mon Nov 09, 2009

Philadelphia Business Journal

Liberty Property sell W. Chester building

A flex building in West Chester traded for $12 million, or more than $90 a square foot, in what is a strong showing for that type of building.

Comment?

Related Topix: West Chester, PA, Liberty Property Trust, Real Estate, Biotech, Medicine, Healthcare Industry

Sat Nov 07, 2009

MediLexicon

Pivotal Data Published In The Journal Cancer Demonstrate That TREANDA ...

Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Pharma Industry / Biotech Industry Cephalon, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lymphoma, Health, Leukemia, Food and Drug Administration

Fri Nov 06, 2009

Drugs.com

Journal Cancer Publishes Pivotal Study of TREANDA in Patients with in Relapsed Indolent NHL

" November 5, 2009 - " Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDAA for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma whose disease had progressed during or within six months of treatment with rituximab.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Lymphoma, Health, Food and Drug Administration, Leukemia

Thu Nov 05, 2009

GuruFocus.com

Alkermes Inc. Reports Operating Results

Alkermes Inc. filed Quarterly Report for the period ended 2009-09-30. Alkermes Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Alkermes, Johnson and Johnson, Cambridge, MA, Waltham, MA

Motley Fool

MFI Stock Review: Cephalon

Cephalon specializes in bio-pharmaceuticals that target central nervous system disorders, pain treatments, and oncology .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Pain, Oncology, Sleep, Lymphoma, Leukemia

Tue Nov 03, 2009

Drugs.com

Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder

Cephalon, Inc. today announced that the November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial demonstrating that NUVIGIL Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with excessive sleepiness associated with shift work disorder .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Provigil, Modafinil (generic), Medication, Food and Drug Administration

Mon Nov 02, 2009

GuruFocus.com

Vanguard Healthcare Fund Buys Q3 Portfolio: CEPH, JNJ, ONXX, CBST

If you think to invest in healthcare industry amid the government controlled reform, you may want to look at Edward Owens a TM Vanguard Healthcare Fund portfolio.

Comment?

Related Topix: Biotech, Medicine, Cubist Pharmaceuticals, Healthcare Industry, Onyx Pharmaceuticals, Johnson and Johnson, Allergan, Financial Markets

Fri Oct 30, 2009

Bioscience Technology

Covidien gets approval for generic pain drug Actiq

Covidien PLC said Friday it expects to start selling a generic version of the painkiller Actiq in early 2010.

Comment?

Related Topix: Food and Drug Administration, Marketing, Medicine, Biotech, Healthcare Industry

The Motley Fool

Don't Miss This Cheap Stock

Cheap stocks can get cheaper . They often do. Unfortunately, "cheap" is a relative term.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Johnson and Johnson

Wed Oct 28, 2009

ABC News

Cephalon Signs Buyout Option Deal With BioAssets

Cephalon paying $30 million upfront in buyout option deal for BioAssets Development.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Oct 27, 2009

ABC News

Biotech Firm Cephalon 3Q Profit Falls 2.7 Percent

Cephalon Inc. on Tuesday said third-quarter earnings fell from a year ago, when the biotech firm recorded a $66.1 million tax benefit.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Bizjournals

Cephalon close to buying BioAssets, developer of sciatica treatment

Cephalon Inc. signed an option agreement Monday to acquire BioAssets Development Corp.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Wellesley, MA

Mon Oct 26, 2009

Medical News

Cephalon, BDC sign option agreement

Cephalon, Inc. and BioAssets Development Corporation , a privately held biopharmaceutical company, today announced that the companies have signed an agreement that will provide Cephalon with an option to acquire BDC.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Tnf, Health, Enbrel, Etanercept (generic), Pain

Sun Oct 25, 2009

The US Market Blog

Thursday Options Recap

Stocks were trading mixed early Thursday, as investors digested another hefty dose of earnings news.

Comment?

Related Topix: Financial Markets, Restaurant Management, Mcdonalds, eBay, Startups, Biotech, Medicine, Healthcare Industry

Fri Oct 23, 2009

Zacks Analyst Blog

CEPH's Nuvigil Faces Generic Threat

Cephalon, Inc. recently received a Paragraph IV Certification Notice Letter regarding an Abbreviated New Drug Application , which has been filed by Teva Pharmaceuticals with the U.S. Food and Drug Administration .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Provigil, Modafinil (generic), Medication

Thu Oct 22, 2009

TheStreet.com

Unusual Call Activity in Cephalon: Options

Although Cephalon did not announce significant news Thursday, at least one investor is taking a bullish stance on the drug manufacturer and boosting call volume days ahead of the company's earnings.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Business News

MarketWatch

Israel Stocks: Israel stocks off: Israel Chemicals, Teva in focus

Israeli stocks were down on Thursday, as strength in Israel Chemicals and its parent were more than offset by broad weakness among the blue chips and the tech sector.

Comment?

Related Topix: Teva Pharmaceutical Industries, Biotech, Israel, World News, Canada, Manufacturing, Elbit Systems, Aerospace-Defense, Food and Drug Administration, Medicine, Healthcare Industry

Fri Oct 16, 2009

The Biotech Stock Blog

Biotech: Q3 Market Update

In Q3 2009, life science and biotech stocks kept pace with market sectors that offer comparable risk and performance such as small-cap growth, science and technology, and midcap growth.

Comment?

Related Topix: Biotech, Science / Technology, Celgene, Medicine, Amgen, Healthcare Industry, Gilead Sciences, Genzyme General

Mon Oct 12, 2009

Democrat & Chronicle

Canandaigua Republican supervisor candidate withdraws from race

David Sauter, the Republican candidate for supervisor in the town of Canandaigua, has dropped out of the race, citing business obligations.

Comment?

Related Topix: Canandaigua, NY, Biotech, Medicine, Healthcare Industry

Farmington Jobs

Also on Topix